Allograft injury mediated by reactive oxygen species: From conserved proteins of Drosophila to acute and chronic rejection of human transplants. Part I: Demonstration of reactive oxygen species in reperfused allografts and their role in the initiation of innate immunity

Transplantation Reviews

Volumn 16, Issue 4, 2002, Pages 192-204

  Land, Walter ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; DROSOPHILA PROTEIN; HEAT SHOCK PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; STAT PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR AP 1;

ALLOGRAFT; APOPTOSIS; CELL DAMAGE; CELL DEATH; CELL FUNCTION; CLINICAL OBSERVATION; GENETIC CONSERVATION; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNITY; IMMUNOCOMPETENT CELL; MEDICAL LITERATURE; ORGAN DONOR; ORGAN TRANSPLANTATION; OXIDATIVE STRESS; PROTEIN FUNCTION; PROTEIN INTERACTION; RECIPIENT; REPERFUSION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION;

EID: 0036822984     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1053/trte.2002.129630     Document Type: Article

References (98)

1. Land W, Schneeberger H, Schleibner ST, et al: The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejetion events in recipients of cadaveric renal transplants. Transplantation 1994, 57:211
2. Land W: The potential impact of the reperfusion injury on acute and chronic rejection events following organ transplantation. Transplant Proc 1994, 26:3169
3. Land W, Messmer K: The impact of ischemia/reperfusion iujury on specific and non-specific, early and late chronic events after organ transplantation. Transplantation Rev 1996, 10:108
4. Kusaka M, Zandi-Nejad K, Kato S, et al: Exploitation of the continuum between early ischemia/reperfusion injury and host alloresponsiveness. Transplantation 1999, 67:1255
5. Mechnikov II: Nobel Lecture, December 11, 1908: "On the present state of the question of immunity in infections diseases." Available at: http://www.nobel.se/medicine/laureates/1908/mechnikov-lecture.html.
6. Medzhitov R, Janeway CA: Innate Immunity: the virtues of a nonclonal system of recognition. Cell 1997, 91:295
7. Medzhitov R, Janeway CA: Innate immunity: impact on the adaptive immune response. Curr Opin lmmunol 1997, 9:4
8. Anderson KV, Jürgens G, Nüsslein-Volhard C: Establishment of dorsal-ventral polarity in the Drosophila embryo: Genetic studies on the role of the Toll gene product. Cell 1985, 42:779
9. Lemaitre B, Nicolas E, Michaut L, et al: The dorsoventral regulatory gene cassette spaetzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996, 86: 973
10. Belvin MP, Anderson KV: A conserved signaling pathway: The Drosophila Toll-Dorsal pathway. Annu Rev Cell Dev Biol 1996, 12:3343
11. Anderson KV: Pinning down positional information: Dorsalventral polarity in the Drosophila embryo. Cell 1998, 95:439
12. Meng X, Khanuja BS, Ip YT: Toll receptor-mediated Drosophila immune response requires Dif, an NF-κB factor. Genes Dev 1999, 13:792
13. Grosshans J, Bergmann A, Haffter P, et al: Activation of the kinase Pelle by tube in the dorsoventral signal transduction pathway of Drosophila embryo. Nature 1994, 372:563
14. Rutschmann S, Jung AC, Hetru C, et al: The Rel protein DIF mediates the antifungal but not the antibacterial host defense in Drosophila. Immunity 2000, 12:569
15. Imler JL, Hoffmann JA: Signaling mechanisms in the antimicrobial host defense of Drosophila. Curr Opin Microbiol 2000, 3:16
16. Medzhitov R, Preston-Hurlburt P, Janeway CA: A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388:394
17. Rock FL, Hardiman G, Timans JC, et al: A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci U S A 1998, 95:588
18. Visintin A, Mazzoni A, Spitzer JH, et al: Regulation of Toll-like receptors in human monocytes and dendritic cells. J Immunol 2001, 166:249
19. Michelsen KS, Aichers A, Mohaupt M, et al: The role of Toll-like receptors (TLRs) in bacteria-induced maturation of murine dendritic cells (DCs)-Peptidoglycan and lipoteichoic acid are inducers of DC maturation and require TTR2- J Biol Chem 2001, 276:25680
20. Kol A, Sukhova GK, Lichtman AH, et al: Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-a and matrix metalloproteinase expression. Circulation 1998, 98:300
21. Kol A, Bourcier T, Lichtman AH, et al: Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J Clin Invest 1999, 103:571
22. Land W: Postischemic reperfusion injury to allografts-A case for innate immunity? Eur Surg Res 2002, 34:160
23. Halliwell B, Gutteridge JMC: Free radicals in biology and medicine (ed 3). Oxford University Press, New York, NY, 2000
24. Kiyoshi N: Role of reactive oxygen species in the regulation of physiological functions. Biol Pharmaceut Bull 2000, 23:897
25. Gamaley IA, Klyubin IV: Roles of reactive oxygen species: Signalling and regulation of cellular functions. Inter Rev Cytol 1999, 188:203
26. Ghosh S, May MJ, Kopp EB: NF-kappaB and Rel proteins: Evolutionary conserved mediators of immune responses. Annu Rev Immunol 1998, 16:225
27. Sha WC: Regulation of immune responses by NF-κB/Rel transcription factors. J Exp Med 1998, 187:143
28. Granger DN, Höllwarth ME, Parks DA: Ischemia-reperfusion injury: Role of oxygen-derived free radicals. Acta Physiol Scand 1986, 548:47
29. McCord JM: Oxygen-derived radicals: a link between reperfusion injury and inflammation. Fed Proc 1987, 46:2402
30. Parks DA, Granger DN: Ischemia-reperfusion injury: A radical view. Hepatology 1988, 8:680
31. Menger MD, Lehr HA, Messmer K: Role of oxygen radicals in the microcirculatory manifestations of postischemic injury. Klin Wochenschr 1991, 69:1050
32. Rabl H, Khoschsorur G, Colombo T, et al: Human plasma lipid peroxide levels show a strong transient increase after successful revascularisation operations. Free Rad Biol Med 1992, 13:281
33. Pincemail J, Defraigne JO, Franssen C, et al: Evidence for free radical formation during kidney transplantation. Free Rad Biol Med 1993, 15:343
34. Davenport A, Hopton M, Bolton C: Measurement of malondialdehyde as a marker of oxygen free radical production during renal allograft transplantation and the effect on early graft function. Clin Transplantation 1995, 9:171
35. Hower R, Minor TH, Schneeberger H, et al: Assessment of oxygen radicals during human kidney transplantation. Effect of radical scavenger. Transpl Int 1996, 9:S479
36. Illner WD, Land W: Comment to the previous paper of J. Zweier: Demonstration of reactive oxygen species in reperfused human kidney transplants. Transplant Proc 1998, 30: 4233
37. Zweier JL, Kuppusamy P, Thompson-Gorman S, et al: Measurement and characterization of free radical generation in reoxygenated human endothelial cells. Am J Physiol 1994, 266:C700
38. Zweier JL, Broderick R, Kuppusamy P, et al: Determination of the mechanism of free radical generation in human aortic endothelial cells exposed to anoxia and reoxygenation. J Biol Chem 1994, 269:24156
39. Duilio C, Ambrosio G, Kuppusamy P, et al: Neutrophils are primary source of O2 radicals during reperfusion after prolonged myocardial ischemia. Am J Physiol Heart Circ Physiol 2001, 280:H2649
40. Fertmann J, Arbogast H, Hoffmann JN, et al: Generation of hydroxyl radicals is increased after reperfusion of human cadaveric renal allografts. 2nd Annual ASTS Winter Symposium, Miami, FL, 2002, abstr 11.
41. Roubaud V, Sankarapandi S, Kuppusamy P, et al: Quantitative measurement of superoxide generation using the spin trap 5-(diethoxyphosphoryl)-5-methyl-l-pyrroline-N-oxide. Anal Biochem 1997, 247:404
42. Fridovich I: Superoxide anion radical (O2-), superoxide dismutases, and related matters. J Biol Chem 1997, 272:18515
43. Kusaka M, Pratschke J, Wilhelm MJ, et al: Activation of inflammatory mediators in rat renal isografts by donor brain death. Transplantation 2000, 69:405
44. Pratschke J, Wilhelm MJ, Laskowski I, et al: Influence of donor brain death on chronic rejection of renal transplants in rats. J Am Soc Nephrol 2001, 12:2474
45. Hampton MB, Orrenius S: Dual regulation of caspase activity by H2O2: Implications for apoptosis. FEBS Lett 1997, 414:552
46. Marnett LJ: Oxyradicals and DNA damage. Carcinogenesis 2000, 21:361
47. Mates JM, Perez-Gomez C, Nunez de Castro I: Antioxidant enzymes and human diseases. Clin Biochem 1999, 32:595
48. Finkel T, Holbrook NJ: Oxidants, oxidative, stress and the biology of ageing. Nature 2000, 408:239
49. Ylä-Herttuala S: Oxidized LDL and atherogenesis. Ann N Y Acad Sci 1999, 874:134
50. Steinberg D: Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997, 272:20963
51. Halliwell B: The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis 1993, 23:118
52. Frei B: On the role of vitamin C and other antioxidants in atherogenesis and vascular dysfunction. Proc Soc Exp Biol Med 1999, 222:196
53. Dean RT, Fu S, Stocker R, et al: Biochemistry and pathology of radical-mediated protein oxidation. Biochem J 1997, 324:1
54. Dean RT, Armstrong SG, Fu S, et al: Oxidized proteins and their enzymatic proteolysis in eucaryotic cells: A critical appraisal, in Nohl H, Esterbauer H, Rice-Evans C, (eds). Free Radicals in the Environment, Medicine, and Toxicology. London, Richelieu Press, 1994, p 47
55. Butterfield DA, Koppal T, Howard B, et al: Structural and functional changes in proteins induced by free radical-mediated oxidative stress and protective action ofthe antioxidants N-tert-butyl-alpha-phenylnitrone and vitamen E. Ann N Y Acad Sci 1998, 854:448
56. Stadtman ER, Berlett BS: Reactive oxygen-mediated protein oxidation in aging and diseases. Drug Metab Rev 1998, 30:225
57. Stadtman ER: Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. Free Radic Biol Med 1990, 9:315
58. Witko-Sarsat V, Friedlander M, Nguyen Khoa T, et al: Advanced oxidation protein products as novel mediatores of inflammation and monocyte activation in chronic renal failure. J Immunol 1998, 161:2524
59. Dushay MS, Asling B, Hultmark D: Origins of immunity: Relish, a compound Rel-like gene in the antibacterial defense of Drosophila. Proc Natl Acad Sci U S A 1996, 93:10343
60. Nicolas E, Reichart JM, Hoffmann JL, et al: In vivo regulation of the IkB homologue cactus during the immune response of Drosophila. J Biol Chem 1998, 273:10463
61. Manfruelli P, Reichart JM, Stewart R, et al: A mosaic analysis in Drosophila fat body cells of the control of antimicrobial genes by the Rel proteins Dorsal and DIF. EMBO J 1999, 18:3380
62. Verma IM, Stevenson JK, Schwarz EM, et al: Rel/NF-kB/IkB family: intimate tales of association and dissociation. Genes Dev 1996, 9:2723
63. Baeuerle PA, Baltimore D: NF-kappa B: Ten years after. Cell 1996, 87:13
64. Baeuerle PA, Henkel T: Function and activation ol NF-κB in the immune system. Annu Rev Immunol 1994, 12:141
65. Baeuerle PA: Pro-inflammatory signaling: last pieces in the NF-κB puzzle? Curr Biol 1998, 8:R19
66. Wesche H, Henzel WJ, Shillinglaw W, et al: MyD88: An adapter that recruits IRAK to the IL-1 receptor complex. Immunity 1997, 7:837
67. Schreck R, Rieber P, Baeuerle PA: Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 1991, 10:2247
68. Schreek R, Meier B, Mannel DN, et al: Dithocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med 1992, 175:1181
69. Schreek R, Albermann K, Baeuerle PA: Nuclear factor kaa b: An oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun 1992, 17:217
70. Flohe L, Brigelius-Flohe R, Saliou, Traber MG, et al: Redox regulation of NF-kappa B activation. Free Radic Biol Med 1997, 22:1115
71. Bonizzi G, Piette J, Schoonbroodt S, et al: Reactive oxygen intermediate-dependent NF-kappaB activation by interleukin-1beta requires 5-lipoxy-genase or NADPA oxidase activity. Mol Cell Biol 1999, 19:1950
72. Bowie A, O'Neill AJ: Oxidative stress and nuclear factor-κB activation.A reassessment of the evidence in the light of recent discoveries. Biochem Pharmacol 2000, 59:13
73. Karin M: The regulation of AP-1 activity by mitogen-activated protein kinases. J Biol Chem 1995, 270:16483
74. Kyriakis JM: Activation of the AP-1 transcription factor by, inflammatory cytokines of the TNF-family. Gene Expr 1999, 7:217
75. Abate C, Patel L, Rauscher FJ 3rd, et al: Redox regulation of fos and jun DNA-binding activity in vitro. Science 1990, 249: 1157
76. Meyer M, Schreck R, Baeuerle PA: H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBOJ 1993, 12:2005
77. Schmidt KN, Amstad P, Cerutti P, et al: The roles of hydrogen peroxide and superoxide as messengers in the activation of transcription factor NF-κB. Chem Biol 1995, 2:13
78. Los M, Schenk H, Hexel K, et al: II-2 gene expression and NF-kappa B activation through CD28 requires reactive oxygen production by 5-lipoxygenase. EMBO J 1995, 14:3731
79. Brigelius-Flohe R, Friedrichs B, Maurer S, et al: Interleukin-l-induced nuclear factor kappa B activation is inhibited by overexpression of phospholipid hydroperoxide gluthadione peroxidase in a human endothelial cell line. Biochem 1997, 328:199
80. Schulze-Osthoff K, Beyaert R, Vandevoorde V, et al: Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inducive effects of TNF. EMBO 1993, 12:3095
81. Bonizzi G, Piette J, Merville M-P, et al: Cell type-specific role for reactive oxygen species in nuclear factor-kappa B activation by interleukin-1. Biochem Pharmacol 2000, 59:7
82. Xanthoudakis Smiao G, Wang F, Pan YC, et al: Redox activation of Fos-Jun DNA binding activity is mediated by, a DNA repair enzyme. Embo J 1992, 11:3323
83. Okuno H, Akahori A, Sato H, et al: Escape from redox regulation enhances the transforming activity of Fos. Oncogene 1993, 8:695
84. Sen CK, Parker L: Antioxidant and redox regulation of gene transcription. FASEB J 1996, 10:709
85. English J, Pearson G, Wilsbacher J, et al: New insights into the control of MAP kinase pathways. Exp Cell Res 1999, 253:255
86. Pearson G, Robinson F, Beers Gibson T, et al: Mitogenactivated protein (MAP) kinase pathways: regulations and physiological functions. Endocrine Rev 2001, 22:153
87. Kyriakis JM, Avruch J: Sounding the alarm: Protein kinase cascades activated by stress and inflammation. J Biol Chem 1996, 271:24313
88. Ip YT, Davis RJ: Signal transduction by the c-Jun N-terminal kinase (JNK)-From inflammation to development. Curr Opin Cell Biol 1998, 10:205
89. Schaeffle HJ, Weber MJ: Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol 1999, 19:2435
90. Han J, Ulevitch RJ: Emerging for anti-inflammatory therapy. Nat Cell Biol 1999, 1:E39
91. Davis RJ: Signal transduction by the JNK group of MAP kinases. Cell 2000, 103:239
92. Chang L, Karin M: Mammalian MAP kinase signalling cascades. Nature 2001, 410:37
93. Simon AR, Rai U, Fanburg BL, et al: Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol 1998, 275:C1640
94. Carballo M, Conde M, El Bekay R, et al: Oxidative stress triggers STAT3 tyrosine phosphorylation and nuclear translocation in human lymphocytes. J Biol Chem 1999, 274:17580
95. Ihle JN, Witthuhn BA, Quelle FW, et al: Signaling by the cytokine receptor superfamily JAKs and STATs. Trends Biochem Sci 1994, 19:222
96. Ihle JN, Witthuhn BA, Quelle FW, et al: Signaling through the hematopoetic cytokine receptors. Annu Rev Immunol 1995, 13:369
97. Watanabe S, Arai K-I: Roles of the JAK-STAT system in signal transduction via cytokine receptors. Curr Opin Genet Dev 1996, 6:587
98. Darnell JE Jr: STATs and gene regulation. Science 1997, 277:1630